CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 8-K Event Material agreement · New debt or obligation · Other events
- 8-K Event Executive or director change · Bylaws or fiscal year change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 313,338 shares (to pay taxes)
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Shareholder vote results
- 4 Open-market sale 10% owner sold 30,204 shares at an average $30.59 ($923,827)
- 8-K Event Other events
- 4 Open-market sale 10% owner sold 4,796 shares at an average $30.03 ($144,024)
- 4 Open-market sale 10% owner sold 15,000 shares at an average $26.13 ($391,904)
- 4/A Open-market sale 10% owner sold 5,000 shares at $29.64 ($148,200)
- 4/A Open-market sale 10% owner sold 5,000 shares at $30.01 ($150,055)
- 10-Q Report Quarterly Report
Page 4 of 44 · 872 filings